News & Updates
Filter by Specialty:

Reduced-dose DOACs tied to lower stroke incidence vs warfarin
Patients with atrial fibrillation receiving a reduced dose of direct acting oral anticoagulants (DOAC), particularly rivaroxaban and dabigatran, show a similar incidence of ischaemic stroke and systemic embolism to those receiving warfarin, a study has shown.
Reduced-dose DOACs tied to lower stroke incidence vs warfarin
10 Jun 2024
Green kiwi may improve GI symptoms in IBS-C patients
Habitual intake of green kiwifruit may effectively relieve abdominal pain and constipation in adults with constipation-predominant irritable bowel syndrome (IBS-C), findings from a study presented at DDW 2024 suggest.
Green kiwi may improve GI symptoms in IBS-C patients
10 Jun 2024
Chemo plus immunotherapy improves survival in advanced endometrial cancer
Adding immunotherapy to the first-line treatment for advanced and metastatic endometrial cancer may significantly improve some oncologic outcomes, particularly within the mismatch repair deficiency/microsatellite instability-hypermutated (MMRd/MSI-H) subset, suggests a study.
Chemo plus immunotherapy improves survival in advanced endometrial cancer
09 Jun 2024
Bispecific antibody delivers positive results in relapsed, refractory multiple myeloma
A large percentage of patients with relapsed/refractory multiple myeloma (RRMM) respond to the bispecific antibody linvoseltamab, with deep and durable responses seen even in the high-risk subgroups, according to data from the phase I/II LINKER-MM1 trial.